Pharmacology Studies and Animal Model Development Tender - 78484213

Procurement Summary

Country: USA

Summary: Pharmacology Studies and Animal Model Development and Related Services for Drug Development

Deadline: 07 Mar 2023

Posting Date: 08 Feb 2023

Other Information

Notice Type: Tender

TOT Ref.No.: 78484213

Document Ref. No.: 75N95023R00004-SS

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

Description
Related Notice: Request for Information, Notice ID 75N95023R00004, Pharmacology Studies and Animal Model Development and Related Services for Drug Development, published November 7, 2022.
PURPOSE OF NOTICE
This is a Research and Development (R&D) Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding the availability and capability of all qualified sources to perform a potential R&D requirement.
This notice is issued to help determine the availability of qualified companies technically capable of meeting the Government requirement and to determine the method of acquisition. It is not to be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. Responses will not be considered as proposals or quotes. No award will be made as a result of this notice. Responses will not be considered as proposals or quotes. The Government will NOT be responsible for any costs incurred by the respondents to this notice. This notice is strictly for research and information purposes only. The Government will not entertain questions regarding the results of this market research.
BACKGROUND
The Therapeutic Development Branch (TDB) within the Division of Preclinical Innovation (DPI) at the National Center for Advancing Translational Sciences (NCATS) within the National Institutes of Health (NIH) conducts translational research to support therapeutic development by moving small molecule and biologic drug candidates forward in the drug development pipeline. Upon reaching predetermined milestones, TDB hands off clinical candidates to external partners to bring these novel therapies to patients. In addition to developing new candidate drugs, TDB seeks to advance the entire field of drug discovery and development by encouraging scientific and technological innovations aimed at improving success rates in t...
Active Contract Opportunity

Notice ID : 75N95023R00004-SS

Related Notice

Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Sub-tier : NATIONAL INSTITUTES OF HEALTH

Office : NATIONAL INSTITUTES OF HEALTH NIDA

General Information

Contract Opportunity Type: Sources Sought (Original)

All Dates/Times are: (UTC-05:00) EASTERN STANDARD TIME, NEW YORK, USA

Original Published Date: Feb 07, 2023 09:48 am EST

Original Response Date: Mar 07, 2023 12:00 pm EST

Inactive Policy: Manual

Original Inactive Date: Mar 10, 2023

Initiative: None
Classification

Original Set Aside:

Product Service Code: AN12 - Health R&D Services; Health care services; Applied Research

NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Place of Performance:

Documents

 Tender Notice

Sources-Sought_75N95023R00004.pdf